Baird analyst Catherine Schulte maintains Thermo Fisher Scientific (NYSE:TMO) with a Outperform and lowers the price target from $621 to $620.
Baird Maintains Outperform on Thermo Fisher Scientific, Lowers Price Target to $620
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.